Seunggeun Lee
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Statistical and computational methods for rare variant association analysis
Open Date: 2016-05-17
Close Date: 2021-04-30
Grant: Close
Statistical methods for rare variant effects in sequencing association studies
Open Date: 2012-06-15
Close Date: 2013-08-31
Articles (9)
Despite substantial progress in genomic foundation models, accurately predicting inter-individual variation in gene expression from DNA sequence alone remains a major challenge. Current sequence-based models, such as Enformer and Borzoi, trained exclusively on the reference genome, cannot capture the effects of individual-specific regulatory variants. Moreover, the acquisition of paired whole-genome and transcriptome data required for personalized modeling is hindered by privacy and data-sharing constraints. To address this limitation, we integrate genomic data synthesis with established statistical frameworks. Our approach generates thousands of synthetic training samples by simulating genetic variation from the 1000 Genomes Project and assigning pseudo-expression labels using PrediXcan, a validated eQTL-based predictor. Because simulated and real expression values differ in scale and distribution, we introduce a preference-based objective that models relative rather than absolute expression patterns. Fine-tuning Enformer through alternating cycles of real-data regression and synthetic-data preference optimization enables efficient learning from both real and synthesized data. Using the GEUVADIS dataset, our framework outperforms AlphaGenome, PrediXcan, and Enformer fine-tuned without synthesized data, demonstrating that simulation-based integration of population-level regulatory knowledge can effectively mitigate data scarcity and improve cross-individual generalization in sequence-based gene expression prediction. Availability and implementation Code and data are available at https://github.com/pacifiic/augment-finetune-genomics .
Year:
2025
Summary Polygenic risk scores (PRSs) are essential tools for predicting individual phenotypic risk but often lack accuracy in non-European ancestry groups. Transfer Learning for Polygenic Risk Scores (TL-PRS) addresses this challenge by leveraging European PRSs to improve prediction in underrepresented ancestries but requires privacy-sensitive individual-level data and has low computational efficiency. Therefore, we introduce Pseudovalidated Transfer Learning for PRS (PTL-PRS), an extension of TL-PRS that incorporates pseudovalidation to eliminate the need for individual-level data and includes further software optimization. For pseudovalidation, PTL-PRS generates pseudo-summary statistics for training and validation and evaluates model performance with the pseudo-R2 metric. To improve computational efficiency, PTL-PRS software was optimized with C++, blockwise early stopping, and direct genotype retrieval. Overall, PTL-PRS enhances usability while maintaining TL-PRS’s predictive performance. Availability and implementation The PTL.PRS R package is publicly available on GitHub at https://github.com/bokeumcho/PTL.PRS. The summary statistics used in this paper are available in the public domain: UK Biobank (https://pheweb.org/UKB-TOPMed), PGS Catalog (https://www.pgscatalog.org), COVID-19 Host Genetics Initiative (https://www.covid19hg.org) and GenOMICC (https://genomicc.org/data).
Year:
2025
Polygenic risk scores (PRSs) are essential tools for predicting individual phenotypic risk but often lack accuracy in non-European ancestry groups. Transfer Learning for Polygenic Risk Scores (TL-PRS) addresses this challenge by leveraging European PRSs to improve prediction in underrepresented ancestries but requires privacy-sensitive individual-level data and has low computational efficiency. Therefore, we introduce PTL-PRS (Pseudovalidated Transfer Learning for PRS), an extension of TL-PRS that incorporates pseudovalidation to eliminate the need for individual-level data and includes further software optimization. For pseudovalidation, PTL-PRS generates pseudo-summary statistics for training and validation and evaluates model performance with the pseudo-R metric. To improve computational efficiency, PTL-PRS software was optimized with C++, blockwise early stopping, and direct genotype retrieval. Overall, PTL-PRS enhances both prediction accuracy and software usability, helping underrepresented populations achieve more accurate genetic risk predictions. Availability and Implementation: The PTL.PRS R package is publicly available on GitHub at https://github.com/bokeumcho/PTL.PRS. The summary statistics used in this paper are available in the public domain: UK Biobank (https://pheweb.org/UKB-TOPMed), PGS Catalog (https://www.pgscatalog.org) and GenOMICC (https://genomicc.org/data). Contact: [email protected]
Year:
2025
Summary The polygenic risk score (PRS) is an important method for assessing genetic susceptibility to diseases; however, its clinical utility is limited by a lack of interpretability tools. To address this problem, we introduce eXplainable PRS (XPRS), an interpretation and visualization tool that decomposes PRSs into genes/regions and single nucleotide polymorphism (SNP) contribution scores via Shapley additive explanations (SHAPs), which provide insights into specific genes and SNPs that significantly contribute to the PRS of an individual. This software features a multilevel visualization approach, including Manhattan plots, LocusZoom-like plots, and tables at the population and individual levels, to highlight important genes and SNPs. By implementing with a user-friendly web interface, XPRS allows for straightforward data input and interpretation. By bridging the gap between complex genetic data and actionable clinical insights, XPRS can improve communication between clinicians and patients. Availability and implementation The XPRS software is publicly available on GitHub at https://github.com/nayeonkim93/XPRS and can see the demo through our cloud-based web service at https://xprs.leelabsg.org/.
Year:
2025
The polygenic risk score (PRS) is an important method for assessing genetic susceptibility to diseases; however, its clinical utility is limited by a lack of interpretability tools. To address this problem, we introduce eXplainable PRS (XPRS), an interpretation and visualization tool that decomposes PRSs into genes/regions and single nucleotide polymorphism (SNP) contribution scores via Shapley additive explanations (SHAPs), which provide insights into specific genes and SNPs that significantly contribute to the PRS of an individual. This software features a multilevel visualization approach, including Manhattan plots, LocusZoom-like plots and tables at the population and individual levels, to highlight important genes and SNPs. By implementing with a user-friendly web interface, XPRS allows for straightforward data input and interpretation. By bridging the gap between complex genetic data and actionable clinical insights, XPRS can improve communication between clinicians and patients.
Year:
2024
Due to their low frequency, estimating the effect of rare variants is challenging. Here, we propose RareEffect, a method that first estimates gene- or region-based heritability and then each variant effect size using an empirical Bayes approach. Our method uses a variance component model, popular in rare variant tests, and is designed to provide two levels of effect sizes, gene/region-level and variant-level, which can provide better interpretation. To adjust for the case-control imbalance in phenotypes, our approach uses a fast implementation of the Firth bias correction. We demonstrate the accuracy and computational efficiency of our method through extensive simulations and the analysis of UK Biobank whole exome sequencing data for 100 traits. Additionally, we show that the effect sizes obtained from our model can be leveraged to improve the performance of polygenic scores, outperforming recently developed methods for rare variant polygenic scoring.
Year:
2024
Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we carried out genome-wide cross-population gene-by-short-sleep and long-sleep duration interaction analyses for three blood pressure traits (systolic, diastolic, and pulse pressure) in 811,405 individuals from diverse population groups. We discover 22 novel gene-sleep duration interaction loci for blood pressure, mapped to genes involved in neurological, thyroidal, bone metabolism, and hematopoietic pathways. Non-overlap between short sleep (12) and long sleep (10) interactions underscores the plausibility of distinct influences of both sleep duration extremes in cardiovascular health. With several of our loci reflecting specificity towards population background or sex, our discovery sheds light on the importance of embracing granularity when addressing heterogeneity entangled in gene-environment interactions, and in therapeutic design approaches for blood pressure management.
Year:
2024
Objective To explore the role of selection bias adjustment by weighting electronic health record (EHR)-linked biobank data for commonly performed analyses. Materials and methods We mapped diagnosis (ICD code) data to standardized phecodes from three EHR-linked biobanks with varying recruitment strategies: All of Us (AOU; n=244,071), Michigan Genomics Initiative (MGI; n=81,243), and UK Biobank (UKB; n=401,167). Using 2019 National Health Interview Survey data, we constructed selection weights for AOU and MGI to be more representative of the US adult population. We used weights previously developed for UKB to represent the UKB-eligible population. We conducted four common descriptive and analytic tasks comparing unweighted and weighted results. Results For AOU and MGI, estimated phecode prevalences decreased after weighting (weighted-unweighted median phecode prevalence ratio [MPR]: 0.82 and 0.61), while UKB’s estimates increased (MPR: 1.06). Weighting minimally impacted latent phenome dimensionality estimation. Comparing weighted versus unweighted PheWAS for colorectal cancer, the strongest associations remained unaltered and there was large overlap in significant hits. Weighting affected the estimated log-odds ratio for sex and colorectal cancer to align more closely with national registry-based estimates. Discussion Weighting had limited impact on dimensionality estimation and large-scale hypothesis testing but impacted prevalence and association estimation more. Results from untargeted association analyses should be followed by weighted analysis when effect size estimation is of interest for specific signals. Conclusion EHR-linked biobanks should report recruitment and selection mechanisms and provide selection weights with defined target populations. Researchers should consider their intended estimands, specify source and target populations, and weight EHR-linked biobank analyses accordingly.
Year:
2024
Motivation In the genome-wide association analysis of population-based biobanks, most diseases have low prevalence, which results in low detection power. One approach to tackle the problem is using family disease history, yet existing methods are unable to address type I error inflation induced by increased correlation of phenotypes among closely related samples, as well as unbalanced phenotypic distribution. Results We propose a new method for genetic association test with family disease history, mixed-model-based Test with Adjusted Phenotype and Empirical saddlepoint approximation, which controls for increased phenotype correlation by adopting a two-variance-component mixed model, accounts for case–control imbalance by using empirical saddlepoint approximation, and is flexible to incorporate any existing adjusted phenotypes, such as phenotypes from the LT-FH method. We show through simulation studies and analysis of UK Biobank data of white British samples and the Korean Genome and Epidemiology Study of Korean samples that the proposed method is robust and yields better calibration compared to existing methods while gaining power for detection of variant–phenotype associations. Availability and implementation The summary statistics and code generated in this study are available at https://github.com/styvon/TAPE. Supplementary information Supplementary data are available at Bioinformatics online.
Year:
2022
Collaborators (36)
Amy Bentley
National Human Genome Research Institute
Nicholas Wareham
Director
University of Cambridge
Brenda WJH Penninx
Professor
-
Joseph McCormick
James H. Steele Professor
-
Renata L Riha
Honorary Reader (Associate Professor)
University of Edinburgh
Alison Mondul
Associate Professor
University of Michigan School of Public Health
Bhramar Mukherjee
-
Lars Fritsche
Research Associate Professor
University of Michigan–Ann Arbor
Vilmundur Gudnason
Professor
University of Iceland
Ayush Giri
Assistant Professor
Vanderbilt University Medical Center
Simon R. Cox
Personal Chair of Brain and Cognitive Ageing
University of Edinburgh
Clint Miller
Associate Professor
Stanford University
Patricia Munroe
Professor of Molecular Medicine
Queen Mary University of London
Timo Lakka
Professor of Medical Physiology
University of Eastern Finland
massimo mangino
Honorary Senior Lecturer
King’s College London
Lisa de las Fuentes
Professor of Medicine and Biostatistics
Washington University School of Medicine
Reedik Mägi
Professor of Bioinformatics
University of Tartu
Rodney Scott
Prof. of Medical Genetics
University of Newcastle Australia
Changwei Li
Associate Professor
University of Texas Southwestern Medical Center
Mary Feitosa
Associate Professor
Washington University School of Medicine
Lorenz Risch
Titularprofessur für das Fach klinische Biochemie
University of Bern
Tanika Kelly
Professor
University of Chicago
Nora Franceschini
Professor
University of North Carolina
Kari North
Professor
University of North Carolina at Chapel Hill
Xu Shi
University of Michigan
Kisung Nam
Seoul National University
Olli T. Raitakari
University of Turku
Christopher Friese
Professor
University of Michigan School of Nursing
Sébastien Thériault
Associate Professor
Laval University
W. James Gauderman
professor
University of Southern California
Brian Cade
Investigator
Brigham and Women's Hospital
SINA A. GHARIB
University of Washington
Kenneth Westerman
Assistant Investigator
Massachusetts General Hospital
Hugues Aschard
Head of Statical Genetics unit
Institut Pasteur
Raymond Noordam
Assistant Professor
Leiden University Medical Center
Valborg Gudmundsdottir
Research Assistant Professor
University of Iceland
Make your next move.
Prepare your application
Review drafts before you send them.